Download PDF
Semin Reprod Med 2017; 35(03): 250-255
DOI: 10.1055/s-0037-1603097
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

A Canary in the Coal Mine: Reproductive Health and Cardiovascular Disease in Women

Molly M. Quinn
1   Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco School of Medicine, San Francisco, California
,
Marcelle I. Cedars
1   Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco School of Medicine, San Francisco, California
› Author Affiliations
Further Information

Publication History

Publication Date:
28 June 2017 (online)

    Permissions and Reprints

Abstract

Cardiovascular disease (CVD) is the leading cause of mortality in women in the United States. Compared with age-matched men, premenopausal women are protected against CVD, yet this difference dissipates after menopause. Hypogonadism underlies the shared increased CVD risk seen in menopause, primary ovarian insufficiency (POI), and hypogonadotropic hypogonadism. Early menarche and PCOS have also been associated with CVD risk factors, highlighting the importance of mediators other than deficient estrogen in the underlying etiology of this female-specific increased risk. Pregnancy complications such as preeclampsia, gestational diabetes, and preterm delivery are also associated with subsequent CV disease and offer early opportunities for the identification of risk. Preliminary evidence suggests a common underlying vascular pathology for ovarian aging and pregnancy complications such as preeclampsia. Research is needed to understand the shared pathophysiology of these female-specific risk factors for CVD and target interventions to change outcomes.

Keywords

cardiovascular disease - menopause - ovarian aging - PCOS - preeclampsia
 

  • References

  • 1 Mozaffarian D, Benjamin EJ, Go AS. , et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation 2015; 131 (04) e29-e322
    CrossrefPubMedGoogle Scholar
  • 2 Garcia M, Mulvagh SL, Merz CN, Buring JE, Manson JE. Cardiovascular disease in women: clinical perspectives. Circ Res 2016; 118 (08) 1273-1293
    CrossrefPubMedGoogle Scholar
  • 3 Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. ; Writing Group. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Circulation 1997; 96 (07) 2468-2482
    CrossrefPubMedGoogle Scholar
  • 4 van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet 1996; 347 (9003): 714-718
    CrossrefPubMedGoogle Scholar
  • 5 Jacobsen BK, Nilssen S, Heuch I, Kvåle G. Does age at natural menopause affect mortality from ischemic heart disease?. J Clin Epidemiol 1997; 50 (04) 475-479
    CrossrefPubMedGoogle Scholar
  • 6 Jacobsen BK, Knutsen SF, Fraser GE. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J Clin Epidemiol 1999; 52 (04) 303-307
    CrossrefPubMedGoogle Scholar
  • 7 Jacobsen BK, Heuch I, Kvåle G. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol 2003; 157 (10) 923-929
    CrossrefPubMedGoogle Scholar
  • 8 Ossewaarde ME, Bots ML, Verbeek AL. , et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology 2005; 16 (04) 556-562
    CrossrefPubMedGoogle Scholar
  • 9 Mondul AM, Rodriguez C, Jacobs EJ, Calle EE. Age at natural menopause and cause-specific mortality. Am J Epidemiol 2005; 162 (11) 1089-1097
    CrossrefPubMedGoogle Scholar
  • 10 Lisabeth LD, Beiser AS, Brown DL, Murabito JM, Kelly-Hayes M, Wolf PA. Age at natural menopause and risk of ischemic stroke: the Framingham heart study. Stroke 2009; 40 (04) 1044-1049
    CrossrefPubMedGoogle Scholar
  • 11 Parashar S, Reid KJ, Spertus JA, Shaw LJ, Vaccarino V. Early menopause predicts angina after myocardial infarction. Menopause 2010; 17 (05) 938-945
    CrossrefPubMedGoogle Scholar
  • 12 Wellons M, Ouyang P, Schreiner PJ, Herrington DM, Vaidya D. Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis. Menopause 2012; 19 (10) 1081-1087
    CrossrefPubMedGoogle Scholar
  • 13 Jansen SC, Temme EH, Schouten EG. Lifetime estrogen exposure versus age at menopause as mortality predictor. Maturitas 2002; 43 (02) 105-112
    CrossrefPubMedGoogle Scholar
  • 14 Matthews KA, Crawford SL, Chae CU. , et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?. J Am Coll Cardiol 2009; 54 (25) 2366-2373
    CrossrefPubMedGoogle Scholar
  • 15 Joakimsen O, Bønaa KH, Stensland-Bugge E, Jacobsen BK. Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis: The Tromsø Study. J Clin Epidemiol 2000; 53 (05) 525-530
    CrossrefPubMedGoogle Scholar
  • 16 De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010; 376 (9744): 911-921
    CrossrefPubMedGoogle Scholar
  • 17 Tao XY, Zuo AZ, Wang JQ, Tao FB. Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis. Climacteric 2016; 19 (01) 27-36
    CrossrefPubMedGoogle Scholar
  • 18 Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006; 13 (02) 265-279
    CrossrefPubMedGoogle Scholar
  • 19 Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton III LJ. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 2006; 7 (10) 821-828
    CrossrefPubMedGoogle Scholar
  • 20 Parker WH, Broder MS, Chang E. , et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol 2009; 113 (05) 1027-1037
    CrossrefPubMedGoogle Scholar
  • 21 Rossouw JE, Prentice RL, Manson JE. , et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297 (13) 1465-1477
    CrossrefPubMedGoogle Scholar
  • 22 Løkkegaard E, Jovanovic Z, Heitmann BL, Keiding N, Ottesen B, Pedersen AT. The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy. Maturitas 2006; 53 (02) 226-233
    CrossrefPubMedGoogle Scholar
  • 23 Rivera CM, Grossardt BR, Rhodes DJ. , et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009; 16 (01) 15-23
    CrossrefPubMedGoogle Scholar
  • 24 Wilmot KA, O'Flaherty M, Capewell S, Ford ES, Vaccarino V. Coronary heart disease mortality declines in the United States from 1979 through 2011: Evidence for stagnation in young adults, especially women. Circulation 2015; 132 (11) 997-1002
    CrossrefPubMedGoogle Scholar
  • 25 Savji N, Rockman CB, Skolnick AH. , et al. Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects. J Am Coll Cardiol 2013; 61 (16) 1736-1743
    CrossrefPubMedGoogle Scholar
  • 26 Sivapalaratnam S, Boekholdt SM, Trip MD. , et al. Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study. Heart 2010; 96 (24) 1985-1989
    CrossrefPubMedGoogle Scholar
  • 27 Feng Y, Hong X, Wilker E. , et al. Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases. Atherosclerosis 2008; 196 (02) 590-597
    CrossrefPubMedGoogle Scholar
  • 28 Qiu C, Chen H, Wen J. , et al. Associations between age at menarche and menopause with cardiovascular disease, diabetes, and osteoporosis in Chinese women. J Clin Endocrinol Metab 2013; 98 (04) 1612-1621
    CrossrefPubMedGoogle Scholar
  • 29 Lakshman R, Forouhi NG, Sharp SJ. , et al. Early age at menarche associated with cardiovascular disease and mortality. J Clin Endocrinol Metab 2009; 94 (12) 4953-4960
    CrossrefPubMedGoogle Scholar
  • 30 Santoro N. Update in hyper- and hypogonadotropic amenorrhea. J Clin Endocrinol Metab 2011; 96 (11) 3281-3288
    CrossrefPubMedGoogle Scholar
  • 31 Practice Committee of American Society for Reproductive Medicine. Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril 2012; 98 (02) 302-307
    CrossrefPubMedGoogle Scholar
  • 32 Tzeng CR, Chang YC, Chang YC, Wang CW, Chen CH, Hsu MI. Cluster analysis of cardiovascular and metabolic risk factors in women of reproductive age. Fertil Steril 2014; 101 (05) 1404-1410
    CrossrefPubMedGoogle Scholar
  • 33 Fourman LT, Fazeli PK. Neuroendocrine causes of amenorrhea--an update. J Clin Endocrinol Metab 2015; 100 (03) 812-824
    CrossrefPubMedGoogle Scholar
  • 34 Bairey Merz CN, Johnson BD, Sharaf BL. , et al; WISE Study Group. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol 2003; 41 (03) 413-419
    CrossrefPubMedGoogle Scholar
  • 35 Rickenlund A, Eriksson MJ, Schenck-Gustafsson K, Hirschberg AL. Oral contraceptives improve endothelial function in amenorrheic athletes. J Clin Endocrinol Metab 2005; 90 (06) 3162-3167
    CrossrefPubMedGoogle Scholar
  • 36 O'Donnell E, Goodman JM, Harvey PJ. Clinical review: Cardiovascular consequences of ovarian disruption: a focus on functional hypothalamic amenorrhea in physically active women. J Clin Endocrinol Metab 2011; 96 (12) 3638-3648
    CrossrefPubMedGoogle Scholar
  • 37 Carmina E, Azziz R. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril 2006; 86 (Suppl. 01) S7-S8
    PubMedGoogle Scholar
  • 38 Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod 2012; 27 (10) 3067-3073
    CrossrefPubMedGoogle Scholar
  • 39 Lauritsen MP, Bentzen JG, Pinborg A. , et al. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone. Hum Reprod 2014; 29 (04) 791-801
    CrossrefPubMedGoogle Scholar
  • 40 Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 2016; 31 (12) 2841-2855
    CrossrefPubMedGoogle Scholar
  • 41 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81 (01) 19-25
    Google Scholar
  • 42 Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy II PF, Fitzpatrick LA. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88 (06) 2562-2568
    CrossrefPubMedGoogle Scholar
  • 43 Shroff R, Kerchner A, Maifeld M, Van Beek EJ, Jagasia D, Dokras A. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J Clin Endocrinol Metab 2007; 92 (12) 4609-4614
    CrossrefPubMedGoogle Scholar
  • 44 Orio Jr F, Palomba S, Cascella T. , et al. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004; 89 (09) 4588-4593
    CrossrefPubMedGoogle Scholar
  • 45 Vryonidou A, Papatheodorou A, Tavridou A. , et al. Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90 (05) 2740-2746
    CrossrefPubMedGoogle Scholar
  • 46 Johnstone EB, Rosen MP, Neril R. , et al. The polycystic ovary post-Rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance. J Clin Endocrinol Metab 2010; 95 (11) 4965-4972
    CrossrefPubMedGoogle Scholar
  • 47 Daan NM, Louwers YV, Koster MP. , et al. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?. Fertil Steril 2014; 102 (05) 1444-1451.e3
    CrossrefPubMedGoogle Scholar
  • 48 Daan NM, Jaspers L, Koster MP. , et al. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features. Hum Reprod 2015; 30 (10) 2376-2386
    CrossrefPubMedGoogle Scholar
  • 49 Cibula D, Cífková R, Fanta M, Poledne R, Zivny J, Skibová J. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod 2000; 15 (04) 785-789
    CrossrefPubMedGoogle Scholar
  • 50 Solomon CG, Hu FB, Dunaif A. , et al. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 2002; 87 (05) 2013-2017
    CrossrefPubMedGoogle Scholar
  • 51 Shaw LJ, Bairey Merz CN, Azziz R. , et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 2008; 93 (04) 1276-1284
    CrossrefPubMedGoogle Scholar
  • 52 Mani H, Levy MJ, Davies MJ. , et al. Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study. Clin Endocrinol (Oxf) 2013; 78 (06) 926-934
    CrossrefPubMedGoogle Scholar
  • 53 Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 1998; 51 (07) 581-586
    CrossrefPubMedGoogle Scholar
  • 54 Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 2000; 52 (05) 595-600
    CrossrefPubMedGoogle Scholar
  • 55 Hudecova M, Holte J, Olovsson M, Larsson A, Berne C, Sundstrom-Poromaa I. Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up. Fertil Steril 2011; 96 (05) 1271-1274
    CrossrefPubMedGoogle Scholar
  • 56 Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod 2003; 18 (01) 199-206
    CrossrefPubMedGoogle Scholar
  • 57 Scott RT, Opsahl MS, Leonardi MR, Neall GS, Illions EH, Navot D. Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age. Hum Reprod 1995; 10 (07) 1706-1710
    CrossrefPubMedGoogle Scholar
  • 58 Chu MC, Rath KM, Huie J, Taylor HS. Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk. Hum Reprod 2003; 18 (08) 1570-1573
    CrossrefPubMedGoogle Scholar
  • 59 Woldringh GH, Frunt MH, Kremer JA, Spaanderman ME. Decreased ovarian reserve relates to pre-eclampsia in IVF/ICSI pregnancies. Hum Reprod 2006; 21 (11) 2948-2954
    CrossrefPubMedGoogle Scholar
  • 60 Yarde F, Maas AH, Franx A. , et al. Serum AMH levels in women with a history of preeclampsia suggest a role for vascular factors in ovarian aging. J Clin Endocrinol Metab 2014; 99 (02) 579-586
    CrossrefPubMedGoogle Scholar
  • 61 Birdir C, Fryze J, Vasiliadis H, Nicolaides KH, Poon LC. Maternal serum anti-Müllerian hormone at 11-13 weeks' gestation in the prediction of preeclampsia. J Matern Fetal Neonatal Med 2015; 28 (08) 865-868
    CrossrefPubMedGoogle Scholar
  • 62 Shand AW, Whitton K, Pasfield A. , et al. Evaluation of anti-Mullerian hormone in the first trimester as a predictor for hypertensive disorders of pregnancy and other adverse pregnancy outcomes. Aust N Z J Obstet Gynaecol 2014; 54 (03) 244-249
    CrossrefPubMedGoogle Scholar
  • 63 Appt SE, Chen H, Clarkson TB, Kaplan JR. Premenopausal antimüllerian hormone concentration is associated with subsequent atherosclerosis. Menopause 2012; 19 (12) 1353-1359
    CrossrefPubMedGoogle Scholar
  • 64 Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WH. A validated model of serum anti-müllerian hormone from conception to menopause. PLoS One 2011; 6 (07) e22024
    CrossrefPubMedGoogle Scholar
  • 65 Rosen MP, Johnstone E, McCulloch CE. , et al. A characterization of the relationship of ovarian reserve markers with age. Fertil Steril 2012; 97 (01) 238-243
    CrossrefPubMedGoogle Scholar
  • 66 Bleil ME, Gregorich SE, McConnell D, Rosen MP, Cedars MI. Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease?. Menopause 2013; 20 (11) 1139-1146
    CrossrefPubMedGoogle Scholar
  • 67 Nerenberg K, Daskalopoulou SS, Dasgupta K. Gestational diabetes and hypertensive disorders of pregnancy as vascular risk signals: an overview and grading of the evidence. Can J Cardiol 2014; 30 (07) 765-773
    CrossrefPubMedGoogle Scholar
  • 68 Chen CW, Jaffe IZ, Karumanchi SA. Pre-eclampsia and cardiovascular disease. Cardiovasc Res 2014; 101 (04) 579-586
    CrossrefPubMedGoogle Scholar
  • 69 Robbins CL, Hutchings Y, Dietz PM, Kuklina EV, Callaghan WM. History of preterm birth and subsequent cardiovascular disease: a systematic review. Am J Obstet Gynecol 2014; 210 (04) 285-297
    CrossrefPubMedGoogle Scholar
  • 70 Rich-Edwards JW, Klungsoyr K, Wilcox AJ, Skjaerven R. Duration of pregnancy, even at term, predicts long-term risk of coronary heart disease and stroke mortality in women: a population-based study. Am J Obstet Gynecol 2015; 213 (04) 518.e1-518.e8
    CrossrefPubMedGoogle Scholar
  • 71 Tanz LJ, Stuart JJ, Williams PL. , et al. Preterm delivery and maternal cardiovascular disease in young and middle-aged adult women. Circulation 2017; 135 (06) 578-589
    CrossrefPubMedGoogle Scholar
  • 72 Kessous R, Shoham-Vardi I, Pariente G, Holcberg G, Sheiner E. An association between preterm delivery and long-term maternal cardiovascular morbidity. Am J Obstet Gynecol 2013; 209 (04) 368.e1-368.e8
    CrossrefPubMedGoogle Scholar